OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 11 - 20 of 707 studies

Metabolic and Endocrine Skin

PsO-Diet: Qualitative Exploration for Psoriasis Weight-Management Research

Background Psoriasis affects two million people in the UK. People with obesity are more likely to develop psoriasis, have more severe symptoms, and respond less well to treatment. Losing weight can improve psoriasis, and doctors are advised to suggest this, but few do. Our patient collaborators were unaware of the link between psoriasis and carrying excess weight. People with psoriasis believe what they eat is important but often feel that their doctors do not have the answers to their questions. Aim To ...

GO TO STUDY Go

Cancer and neoplasms

Creating patient-centred infrastructures to enhance informed consent and improve patient experience of radiotherapy for gynaecological cancers (GRACE)

Consent for radiotherapy treatment for cancer takes place in emotional circumstances, often focusing on cure or extending life. The impact of treatment on the quality of life after cancer is less regularly discussed. Previous research conducted by the project team revealed that some patients said they didn’t fully understand what their treatment would involve. Some felt unprepared for the impacts on life afterwards. The aim of this study is to improve how people make decisions about consent for radiotherapy ...

GO TO STUDY Go

Neurological

A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy (BHV7000-201)

This is a Phase 2, global, multicenter, long-term safety study designed to assess the safety and tolerability of BHV-7000 in participants with focal refractory epilepsy. Approximately 660 eligible subjects will enter this study after completing the DBP of either the BHV7000-302 or BHV7000- 303 studies. In the opinion of the investigator, subjects must have tolerated BHV7000/placebo, during participation in the DBP of the parent studies, BHV7000-302 or BHV7000-303 to be eligible. Eligible subjects who completed the DBP of the BHV7000-302 study will ...

GO TO STUDY Go

Cardiovascular

Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II (COSIRA-II)

This study is designed for the patients with coronary artery disease (CAD) who experience severe chest pain (refractory angina) despite taking the best available medications. These patients also have evidence of reversible Ischemia (reduced blood flow), but they are considered high-risk or unsuitable for heart surgery or other currently available medical procedures aimed at restoring blood flow (revascularization procedures). A heart team, including specialists such as cardiologists and surgeons, helps determine their eligibility for the study. Shockwave Medical, Inc. has developed ...

GO TO STUDY Go

Injuries and accidents

Systematic Assessment for the Medical Utility of Radiology Artificial Intelligence – Prospective Evaluation (SAMURAI-Pro)

Prospective cluster randomised cross-over trial We will conduct a prospective cluster randomised cross-over trial (ABAB/BABA) to assess the impact of an AI fracture detection tool in EDs and MIUs in the UK. The trial will involve installing a CE-approved AI algorithm at each site for six months. Sites will be randomly assigned to begin the trial with the AI algorithm either active ("On") or inactive ("Off") during the first month. Thereafter,the algorithm status will alternate each ...

GO TO STUDY Go

Injuries and accidents

TBI-REPORTER Prospective Proof of Principle Study (3P Study)

The 3P project is the foundational study of the TBI-REPORTER Experimental Medicine Network. It will establish the standardisation of protocols for collaborative research within TBI-REPORTER, and demonstrate the feasibility of recruitment and delivery across multiple TBI research centres. The data and samples that emerge in this protocol will allow us to carry out exploratory pilot analyses to allow the rational design of future interventional studies. Thus, the project has the potential to improve current health care and its delivery at ...

GO TO STUDY Go

Infection Inflammatory and immune system

Observational pilot study of the diagnostic potential of a rapid point-of-care blood test in detecting sepsis in an Emergency Department (ED) setting

Sepsis is a life-threatening emergency that happens when your body's response to an infection damages vital organs which can often lead to death. In the UK, there are about 245,000 sepsis cases leading to around 48,000 deaths each year, making it a leading cause of death in the UK. Despite considerable recent progress, detecting sepsis in the Emergency Department (ED) remains a challenge. Paramedics and ED doctors often miss signs of sepsis, with the current National Early Warning Score which is ...

GO TO STUDY Go

Renal and Urogenital

Implementation of Metformin theraPy to Ease Decline of kidney function in Polycystic Kidney Disease (IMPEDE-PKD) Randomised Placebo-Controlled Trial

IMPEDE-PKD is a global trial evaluating the long-term efficacy of metformin therapy in slowing the rate of kidney function decline in metformin versus placebo treated Autosomal Dominant Polycystic Kidney Disease (ADPKD) subjects. The UK trial is assessing a primary outcome of change in pain severity from randomisation to 24 months measured using an 11 point numerical rating score (NRS) of average pain over the last 14 days in the ADPKD Pain Assessment Tool (APAT). It is a phase III,international,prospective,multicentre,double-blind,parallel group,placebo-controlled,randomised trial. Secondary ...

GO TO STUDY Go

Cancer and neoplasms

A prospective cross-sectional multi-centre study to assess the diagnostic accuracy of a panel of bacterial gene markers (M3) for colorectal advanced neoplasia (M3-PRO)

The NHS bowel cancer screening check is offered to everyone over the age of 50. This is a home test kit, called a faecal immunochemical test (FIT). It is used to collect a small sample of stool (poo) which is sent to a lab to be checked for tiny amounts of blood. Your GP may also order a FIT if you have had a change in bowel habits or are experiencing abdominal (tummy) pain. In this study we will be ...

GO TO STUDY Go

Cancer and neoplasms

Integrated molecular and clinical profiling to improve disease characterization and outcome prediction in nodal marginal zone lymphoma (IELSG52)

Already existing and coded tumor biological material from the lymph node biopsy and personal health-related data of patients who have been diagnosed with NMZL will be collected retrospectively.The value of the expected results of the IELSG52 study are: (i) to inform on diagnosis and prognosis of NMZL; (ii) to allow selection of optimal therapy; and (iii) to provide a biology based framework on which to design and interpret clinical trials

GO TO STUDY Go